1. Home
  2. GOOS vs ELVN Comparison

GOOS vs ELVN Comparison

Compare GOOS & ELVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GOOS
  • ELVN
  • Stock Information
  • Founded
  • GOOS 1957
  • ELVN 2016
  • Country
  • GOOS Canada
  • ELVN United States
  • Employees
  • GOOS N/A
  • ELVN N/A
  • Industry
  • GOOS
  • ELVN Biotechnology: Pharmaceutical Preparations
  • Sector
  • GOOS
  • ELVN Health Care
  • Exchange
  • GOOS Nasdaq
  • ELVN Nasdaq
  • Market Cap
  • GOOS 941.0M
  • ELVN 1.1B
  • IPO Year
  • GOOS 2017
  • ELVN 2020
  • Fundamental
  • Price
  • GOOS $8.01
  • ELVN $16.53
  • Analyst Decision
  • GOOS Sell
  • ELVN Strong Buy
  • Analyst Count
  • GOOS 5
  • ELVN 4
  • Target Price
  • GOOS $9.50
  • ELVN $39.25
  • AVG Volume (30 Days)
  • GOOS 980.8K
  • ELVN 359.8K
  • Earning Date
  • GOOS 05-15-2025
  • ELVN 05-13-2025
  • Dividend Yield
  • GOOS N/A
  • ELVN N/A
  • EPS Growth
  • GOOS 51.35
  • ELVN N/A
  • EPS
  • GOOS 0.51
  • ELVN N/A
  • Revenue
  • GOOS $917,088,739.00
  • ELVN N/A
  • Revenue This Year
  • GOOS $0.91
  • ELVN N/A
  • Revenue Next Year
  • GOOS $4.53
  • ELVN N/A
  • P/E Ratio
  • GOOS $15.31
  • ELVN N/A
  • Revenue Growth
  • GOOS 4.16
  • ELVN N/A
  • 52 Week Low
  • GOOS $6.73
  • ELVN $13.30
  • 52 Week High
  • GOOS $14.75
  • ELVN $30.03
  • Technical
  • Relative Strength Index (RSI)
  • GOOS 46.86
  • ELVN 40.34
  • Support Level
  • GOOS $7.66
  • ELVN $15.49
  • Resistance Level
  • GOOS $8.01
  • ELVN $18.14
  • Average True Range (ATR)
  • GOOS 0.47
  • ELVN 1.93
  • MACD
  • GOOS 0.10
  • ELVN -0.17
  • Stochastic Oscillator
  • GOOS 83.12
  • ELVN 41.09

About GOOS Canada Goose Holdings Inc. Subordinate Voting Shares

Canada Goose Holdings Inc is a Canada-based company that designs, manufactures, distributes, and retails premium outerwear for men, women, and children. It operates business through three segments namely, Wholesale and Direct to Consumer (DTC), Other. The DTC segment, which is the key revenue driver, comprises sales through country-specific e-commerce platforms and its company-owned retail stores located in luxury shopping locations. The Wholesale segment comprises sales made to a mix of functional and fashionable retailers, including major luxury department stores, outdoor specialty stores, individual shops, and international distributors. Geographically, it has a presence in Canada, the United States, Asia, Europe, and the Rest of the World.

About ELVN Enliven Therapeutics Inc.

Enliven Therapeutics Inc is a clinical-stage precision oncology company focused on the discovery and development of potentially first-in-class precision oncology therapies. Enliven's programs are designed to address issues such as tolerability, combinability, resistance and disease escape through brain metastases. Its product candidates include ELVN-001 which is a potent, selective, small molecule kinase inhibitor designed to specifically target the BCR-ABL gene fusion, the oncogenic driver for patients with chronic myeloid leukemia, and the ELVN-002 which is central nervous system (CNS) penetrant and irreversible HER2 inhibitor with activity against wild type HER2 and various HER2 mutations.

Share on Social Networks: